Skip to main content
Supplement ScienceSupplementScience

Benefits of Schisandra Berry

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Liver enzyme reduction — Ip et al. (1996) demonstrated that schisandrin B significantly reduced elevated ALT and AST in carbon tetrachloride-induced liver injury models, with protective effects comparable to silymarin at equivalent doses.
  • Detoxification enzyme enhancement — schisandra lignans induce both Phase I (CYP450) and Phase II (glutathione S-transferase, UDP-glucuronosyltransferase) enzymes, accelerating the metabolism and clearance of toxins and drugs from the liver (Panossian & Wikman, 2008).
  • Hepatocyte membrane stabilization — schisandrin B protects liver cell membranes from lipid peroxidation and reduces oxidative damage by increasing hepatic glutathione (GSH) levels (Ko et al., 1995).
  • Anti-inflammatory effects — schisandra lignans inhibit NF-κB-mediated inflammatory signaling in hepatocytes, reducing TNF-α and IL-6 production in liver tissue (Guo et al., 2008).
  • Liver regeneration support — schisandrin C promotes hepatocyte proliferation and accelerates liver regeneration after partial hepatectomy in animal models (Zhu et al., 2000).

What the Research Says

Schisandra berry has a well-established pharmacological profile for liver protection. Ip et al. (1996) provided key evidence for schisandrin B's hepatoprotective effects, showing dose-dependent reductions in liver enzymes in chemical injury models. Panossian and Wikman (2008) published a comprehensive review establishing schisandra's dual induction of Phase I and Phase II detoxification enzymes, a mechanism that accelerates toxin clearance. Ko et al. (1995) demonstrated that schisandrin B increases hepatic glutathione levels, providing an antioxidant defense mechanism. The Chinese Pharmacopoeia and Korean Pharmacopoeia both include Schisandra chinensis as an official hepatoprotective medicine. While most evidence comes from preclinical studies and traditional use, the pharmacological mechanisms are well-characterized and multiple clinical studies from Asian medical literature support its use.

References

  1. ReviewPanossian A, Wikman G (2008). Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine. Journal of Ethnopharmacology. DOI PubMed
  2. ObservationalGuo LY, Hung TM, Bae KH, Shin EM, Zhou HY, Hong YN, Kang SS, Kim HP, Kim YS (2008). Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. European Journal of Pharmacology. DOI PubMed